249 related articles for article (PubMed ID: 11601235)
1. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
Guo Y; Bian S; Luo M
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
3. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
4. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
Drexler HG; Quentmeier H
Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells.
Matsumura I; Kanakura Y; Ikeda H; Ishikawa J; Yoshida H; Horikawa Y; Nishiura T; Tahara T; Kato T; Miyazaki H; Matsuzawa Y
Leukemia; 1996 Jan; 10(1):91-4. PubMed ID: 8558944
[TBL] [Abstract][Full Text] [Related]
6. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin.
Souyri M
Semin Hematol; 1998 Jul; 35(3):222-31. PubMed ID: 9685168
[TBL] [Abstract][Full Text] [Related]
7. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin.
Matsumura I; Kanakura Y; Kato T; Ikeda H; Ishikawa J; Horikawa Y; Hashimoto K; Moriyama Y; Tsujimura T; Nishiura T
Blood; 1995 Jul; 86(2):703-9. PubMed ID: 7541672
[TBL] [Abstract][Full Text] [Related]
8. Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia.
Hirai H; Shimazaki C; Yamagata N; Goto H; Inaba T; Kikuta T; Sumikuma T; Sudo Y; Ashihara E; Fujita N; Hibi S; Imashuku S; Ito E; Nakagawa M
Eur J Haematol; 1997 Jul; 59(1):38-46. PubMed ID: 9260579
[TBL] [Abstract][Full Text] [Related]
9. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
Li J; Sabath DF; Kuter DJ
Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
[TBL] [Abstract][Full Text] [Related]
10. Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia.
Tokunaga Y; Miyamoto T; Okamura T; Eto T; Gondo H; Kamimura T; Okamura S; Niho Y
Br J Haematol; 1998 Sep; 102(5):1232-40. PubMed ID: 9753051
[TBL] [Abstract][Full Text] [Related]
11. The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells.
Matsumura I; Ikeda H; Kanakura Y
Leuk Lymphoma; 1996 Nov; 23(5-6):533-8. PubMed ID: 9031083
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.
Kuwana M; Okazaki Y; Kajihara M; Kaburaki J; Miyazaki H; Kawakami Y; Ikeda Y
Arthritis Rheum; 2002 Aug; 46(8):2148-59. PubMed ID: 12209520
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
14. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.
Matsumura I; Kanakura Y; Kato T; Ikeda H; Horikawa Y; Ishikawa J; Kitayama H; Nishiura T; Tomiyama Y; Miyazaki H; Matsuzawa Y
Blood; 1996 Oct; 88(8):3074-82. PubMed ID: 8874206
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cells.
Kirshenbaum AS; Akin C; Goff JP; Metcalfe DD
Exp Hematol; 2005 Apr; 33(4):413-21. PubMed ID: 15781331
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.
Ayala RM; Martínez-López J; Albízua E; Diez A; Gilsanz F
Am J Hematol; 2009 Feb; 84(2):79-86. PubMed ID: 19097174
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
18. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
[TBL] [Abstract][Full Text] [Related]
20. Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor.
Ikeda H; Kanakura Y; Furitsu T; Kitayama H; Sugahara H; Nishiura T; Karasuno T; Tomiyama Y; Yamatodani A; Kanayama Y
Exp Hematol; 1993 Dec; 21(13):1686-94. PubMed ID: 7694869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]